Connect with us

Market Reports

Global Antacid Market, Trends, Analysis, Opportunities, Share and Forecast – 2019-2025

Published

on

Press Release

The growingincrease prevalence of gastric diseases has led the healthcare and pharmaceuticals providers towards the development of more enhanced gastric solution to get relief from acidity and heartburns. Antacids are the class of drugs thatwhich reduces gastric acidity resulting in the increase pH of the stomach and duodenum. The growing prevalence of gastric diseases among geriatric population has led to the increase in demand for antacids. 

The advancement of e-commerce industry coupled with the consumer preference for online medication due to ease of availability of drugs and home delivery services has propelled the demand for antacids. The increasing adoption of self-medication and ease of availability of various over-the-counter antacids has increased the market share of antacids. Moreover, the population of Gastroesophageal reflux disease, or GERD, has increased significantly resulting in the growingincreased demand for antacids. The various factors leading to the gastric diseases are unhealthy diet, lack of proper sleep, and lack of physical activities. This hasve resulted in the accelerated market share of antacids.

Antacid Market is valued approximately USD 6.13 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 3.9% over the forecast period 2019-2026.

To request a sample copy or view summary of this report, click the link below:
http://www.digitsnmarkets.com/sample/6422-antacid-market

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

  • H2 Antagonist
  • Proton pump inhibitors
  • Acid neutralizers

By Formulation:

  • Tablet
  • Liquid
  • Powder

The regional analysis of Antacid market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific region is expected to register considerable growth over the forecast period owing to consumer awareness, rising investment by market players and growing disposable income have increased the market share of antacids. Moreover, availability of effective treatment methods has fostered the demand for antacids.

Major market player included in this report are:

  • GlaxoSmithKline plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • Pfizer Inc.
  • Abbott Laboratories
  • Dabur India Ltd.
  • GlaxoSmithKline plc
  • Sun Pharmaceuticals Ltd.
  • Procter & Gamble
  • Piramal Enterprises

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Global Market

Global High Definition Breast Tomosynthesis Market is expected to grow at a CAGR of 13.5% from 2020 to 2027

Published

on

Press Release

Breast tissues attain different morphology at different stages of life primarily influenced by the hormonal levels and environmental factors affecting the human body. High definition tomosynthesis is an up-gradation to the earlier versions of digital breast tomosynthesis which is useful in achieving high-resolution images and videos of breast cancer cells and tissue under investigation. Breast tomosynthesis employs a low radiation dose by employing an x-ray tube that moves like an arc achieving breast images from different angles to create multiple data points that can be reconstructed in different ways for effective diagnosis of breast cancer cases.

2D/3D combination systems are presently leading the product segment for high definition breast tomosynthesis market. The major factor responsible for its technical viability among oncologists is its capability to precisely analyze the calcification and no calcification cases of breast cancer which is relatively difficult to analyze by employing either dimensional system. Standalone 3D systems are very crucial in screening breast cancer owing to its excellent ergonomic features such as increased sensitivity and reduced recalls rendering it to effectively diagnose invasive cancer cases and reduction in false-positive cases.

Browse the full report High Definition Breast Tomosynthesis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/high-definition-breast-tomosynthesis-market

Hospitals are dominating the end-user segment for the high definition breast tomosynthesis market. The primary health care centers are the first point of contact for patients opting for early screening of breast cancer. Government health agencies are providing huge funds for the establishment of well-equipped devices for performing screening of breast cancer. Diagnostic centers have gained tremendous traction in the last decade on account of the availability of a skilled workforce for the operating of sophisticated breast tomosynthesis devices and precise interpretation of images.

North America is holding the largest market share in the geography segment for high definition breast tomosynthesis market. As per the research citings brought forward by the American Cancer Society (ACS) in 2019 in the United States approximately 268,600 new cases of breast cancer were reported among the women population. Existence of key players such as Hologic, Inc., GE Healthcare, Siemens Healthineers further propel the market growth pertaining to high definition breast tomosynthesis in the region. In Europe the number of breast cancer cases among the female population as diagnosed in 2018 was 562,500 according to the statistics of the European Breast Cancer Coalition. The strategic collaboration between academic research institutes and medical device manufacturers for the development of breast tomosynthesis devices. Asia Pacific is set to register impressive growth during the forecast period owing to the increasing public health awareness related to the benefits of early screening in breast cancer and developing healthcare infrastructure.

Medical device manufacturers pioneering in the production of high definition breast tomosynthesis are Siemens Healthineers, GE Healthcare, Fujifilm Corporation, Hologic, Inc., Agfa-Gevaert, IMS GIOTTO S.p.A., PLANMED OY., Dexela Ltd., Carestream Health and Metaltronica S.p.A.

Market Key Takeaways:

  • Rising prevalence of breast cancer worldwide
  • Technological advancement and up gradation in the breast tomosynthesis devices to achieve high-resolution images
  • Strategic collaboration between academic research institutes and medical device manufactures to develop high definition breast tomosynthesis devices

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Delapril Hydrochloride Market Is Expected to Grow at a CAGR of 2.3% from 2020 to 2027

Published

on

Press Release

Delapril hydrochloride is a prodrug that gets converted to active metabolite 5-hydroxy delapril diacid which exerts its antihypertensive activity by preventing the conversion of angiotensin 1 to angiotensin 2, thereby enhancing the excretion of sodium and hence causing an increase in water outflow.

Hypertension is presently spearheading the clinical application segment for the delapril hydrochloride market. As per the latest statistics provided by the World Health Organization (WHO), approximately two-thirds of the global cases of hypertension are occurring in low and middle-income countries. It is considered a serious medical condition that increases the risk of damaging internal organs such as the brain, kidney, heart, lungs, etc. Further research studies convey that 1 in 4 men and 1 in 5 women suffer from hypertension worldwide. Type 2 diabetes with hypertension is anticipated to be the fastest-growing clinical application segment for the delapril hydrochloride market. As per the latest research citings presented by the American Diabetes Association (ADA), the coexistence of type 2 diabetes and hypertension increases 4 fold risk of developing heart stroke and end-stage kidney disease in a later stage of life.

Browse the full report Delapril Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/delapril-hydrochloride-market

Combination therapy is the largest and fastest segment in the delapril hydrochloride market. Delapril is used in combination with manidipine and indapamide for the effective management of hypertension. Delapril 30 mg /indapamide 2.5 mg is beneficial in hypertensive patients who are at greater risk of suffering from a cerebrovascular stroke in later stages of life. The combination of manidipine 10mg/delapril 30mg is prescribed for managing hypertension in type 2 diabetic patients owing to its renoprotective properties. Monotherapy of delapril is currently used in a few countries in the European countries such as Italy, Spain, and Germany, etc. owing to its ability to reduce the mortality rate associated with hypertension in the geriatric population.

Europe is presently dominating the geography segment for the delapril hydrochloride market. The rising prevalence of hypertension in the younger population in the European Union region primarily drives its market growth. The major causative agents for the occurrence of hypertension are obesity, sedentary lifestyle, unhealthy diet, stress, etc. As per the latest research citings presented by the European Heart Network (EHN) cardiovascular diseases are responsible for 45% of all the deaths in the European region. Affordable reimbursement scenario and favorable regulatory environment provided by the European Medical Agency (EMA), for the manufacturing and sale of delapril hydrochloride further accentuates its market growth in the region. Delapril hydrochloride is not available in North America. Asia Pacific is expected to register rampant market growth during the forecast period. A significant increase in the elderly population type 2 diabetes with hypertension drives the delapril hydrochloride market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of delapril hydrochloride are Chiesi Farmaceutici s.p.a., Promedica Srl, Tokyo Chemical Industry Co., Ltd, Glentham Life Sciences Ltd, LGM Pharma, IWAKI SEIYAKU CO., LTD., Merck KGaA., and MASTER PHARMA Srl.

Key Market Movements:

  • Significant increase in the early onset of hypertension in young adult population worldwide
  • A constant rise in the number of type 2 diabetic patients suffering from hypertension
  • Supportive regulatory environment provided by the global healthcare agencies for the monotherapy and combination therapy of delapril hydrochloride throughout the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Medicinal Mushroom Extracts Market is expected to grow at a CAGR of 9.3% from 2020 to 2027

Published

on

Press Release

Medicinal mushrooms are fungal organism which is used as a nutritional supplement and healthy food in daily diet. Rising prevalence of lifestyle disorders and rising public health awareness together drive the medicinal mushroom extracts market growth.

Reishi medicinal mushroom is presently leading the type segment for the medicinal mushroom extract market. It is being used by the royal families since ages for its ability to increase longevity & antiageing properties and hence known as the mushroom of immortality. Reishi comprises ganoderic acid which is critical in reducing high blood pressure and cholesterol levels. Reishi also possesses important properties such as antiviral, antibacterial, etc. and is essential in boosting the immune system. The Chaga medicinal mushroom will be the fastest-growing type segment during the forecast period on account of its immunomodulation properties by stimulating the production of antibodies to fight the invading virus and pathogens. Diligent research has led to the conclusion that it is beneficial in treating autoimmune diseases such as psoriasis, rheumatoid arthritis, etc.

Browse the full report Medicinal Mushroom Extracts Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medicinal-mushroom-extracts-market

Immunity enhancers are spearheading the clinical application segment for the medicinal mushroom extracts market. As per the World Bank report in 2017, the global healthcare burden associated with communicable disease and nutritional deficiency was 28% due to low immunity in infected patients. Medicinal mushrooms are vital in enhancing immunity by stimulating lymphocytes, cytokines, macrophages, etc. Anticancer clinical application will be showcasing comfortable market growth in the near future owing to the rising prevalence of cancer worldwide. Pharmacological active compounds such as lectins, schizophyllan, lentinan, active hexose correlated compounds, etc. have proved beneficial in the treatment of various cancers such as breast, cervical, colorectal, skin, etc.

North America is the clear leader in the geography segment for the medicinal mushroom extracts market. The rising prevalence of cancer significantly increases the demand for medicinal mushroom extracts in the North American region. As per the latest information provided by the American Cancer Society (ACS), in 2019 approximately 140,690 new cases of cancer were reported in the United States. Rising public health awareness and increasing inclination for the adoption of medicinal mushroom extracts as a nutraceutical supplement further consolidates the market growth in the region. Europe stood second in the regional segment for the medicinal mushroom extracts market. The constant increase in viral infections on account of compromised immunity determines the medicinal mushroom extracts market growth in the region. Asia Pacific is going to be the fastest-growing regional segment on account of the significant increase in the geriatric population suffering from autoimmune diseases.

Nutraceutical companies actively engaged in the provision of medicinal mushroom extracts areNammex, Amax NutraSource, Inc., Oriveda BV, Bio-Botanica, Inc., Nutra Green Biotechnology Co., Ltd., Yuikiguni Maitake Corp., Xian Yuensun Biological Technology Co., Ltd., Nyishar, Hokkaido Reishi Co. Ltd., and Aloha Medicinals, Inc.

Market Key Takeaways:

  • Constant rise in chronic lifestyle disease worldwide
  • Rising public health awareness and growing inclination pertaining to the adoption of medicinal mushroom extracts as a dietary supplement
  • Systematic scientific verification of active compounds present in the medicinal compounds will further increase the demand for medicinal mushroom extracts in Lifesciences industry

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Trending

Copyright © 2019 Melanian News